Tag: MS relapse

Neurology

PRAC Restricts Use of Alemtuzumab for MS Pending Ongoing Review

Newsemia
The EMA committee recommends updating the product information to note the potential for acute immune-mediated conditions, stroke, cervicocephalic arterial dissection, and severe neutropenia. News Alerts...
Neurology

MS Linked to Alterations in Bile Acid Metabolism

Newsemia
Abnormalities of these cholesterol metabolites in both children and adults with MS, along with encouraging preclinical findings, have spurred a clinical trial to assess supplementation...
Neurology

Novel Anti-B-Cell Therapy Looks Promising in MS

Newsemia
A new and novel oral therapy for multiple sclerosis, which inactivates rather than depletes B cells, has shown promising results in its first efficacy study....
Neurology

Years of Thyroid Monitoring Needed After MS Drug Alemtuzumab

Newsemia
New study shows fluctuating patterns of thyroid dysfunction and later onset than previously seen associated with the MS drug alemtuzumab, suggesting the need for ongoing...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy